Evidence map›Paper›PMID 27148228›Full record

ArticleFrontiers in microbiology2016

Shortcomings of the Commercial MALDI-TOF MS Database and Use of MLSA as an Arbiter in the Identification of Nocardia Species.

Gema Carrasco, Juan de Dios Caballero, Noelia Garrido, Sylvia Valdezate, Rafael Cantón, Juan A Sáez-Nieto

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. PulmonaryCase reports in infectious diseases · 2026
    Article
  2. Genomic and phenotypic characterization of antimicrobial resistance in clinicalFrontiers in cellular and infection microbiology · 2025
    Article
  3. Article
  4. Article
  5. Clinical screening of Nocardia in sputum smears based on neural networks.Frontiers in cellular and infection microbiology · 2023
    Article
  6. Updated Review onClinical microbiology reviews · 2022
    Review
  7. Article
  8. Identification of Potential Probiotics Producing Bacteriocins Active againstInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Answer to July 2018 Photo Quiz.Journal of clinical microbiology · 2018
    Article
  13. Article
  14. The Complexities of Nocardia Taxonomy and Identification.Journal of clinical microbiology · 2018
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gema CarrascoÁrea de Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid Spain.
Juan de Dios CaballeroServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid Spain.
Noelia GarridoÁrea de Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid Spain.
Sylvia ValdezateÁrea de Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid Spain.
Rafael CantónServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid Spain.
Juan A Sáez-NietoÁrea de Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocardia species are difficult to identify, a consequence of the ever increasing number of species known and their homogeneous genetic characteristics. 16S rRNA analysis has been the gold standard for identifying these organisms, but proteomic techniques such as matrix-assisted laser desorption ionization-time of flight (MALDI-TOF MS) and housekeeping gene analysis, have also been explored. One hundred high (n = 25), intermediate (n = 20), and low (n = 55) prevalence (for Spain) Nocardia strains belonging to 30 species were identified via 16S rRNA and MALDI-TOF MS analysis. The manufacturer-provided database MALDI Biotyper library v4.0 (5.627 entries, Bruker Daltonik) was employed. In the high prevalence group (Nocardia farcinica, N. abscessus, N. cyriacigeorgica and N. nova), the 16S rRNA and MALDI-TOF MS methods provided the same identification for 76% of the strains examined. For the intermediate prevalence group (N. brasiliensis, N. carnea, N. otitidiscaviarum and N. transvalensis complex), this figure fell to 45%. In the low-prevalence group (22 species), these two methods were concordant only in six strains at the species level. Tetra-gene multi-locus sequencing analysis (MLSA) involving the concatemer gyrB-16S rRNA-hsp65-secA1 was used to arbitrate between discrepant identifications (n = 67). Overall, the MLSA confirmed the results provided at species level by 16S rRNA analysis in 34.3% of discrepancies, and those provided by MALDI-TOF MS in 13.4%. MALDI-TOF MS could be a strong candidate for the identification of Nocardia species, but only if its reference spectrum database improves, especially with respect to unusual, recently described species and species included in the described Nocardia complexes.

Indexed as

16S rRNA identificationMALDI-TOF MSMLSANocardia spp.prevalence in Spain

Identifiers

PMID27148228
PMCPMC4838697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.